Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee: Saxagliptin and Cardiovascular Outcomes

Title	Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee: Saxagliptin and Cardiovascular Outcomes
Date	Tuesday, April 14, 2015
Link	View the Advisory Committee Meeting Materials here
Related Links	Anti-Diabetes Drugs and Acute Myocardial Infarction, Hospitalized Heart Failure Completed ARIA Assessments & Impact
Medical Product	saxagliptin sitagliptin
Health Outcome	acute myocardial infarction (AMI) heart failure

Search form